Gujarat Terce Laboratories Ltd Financials
Company Logo

Gujarat Terce Laboratories Ltd Financial Statement

Gujarat Terce Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue13.38
Operating Expense11.64
Net Profit1.48
Net Profit Margin11.06
Earning Per Share2.00
EBIDTA1.70
Effective Tax RateTBA

Gujarat Terce Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual47.97
Operating Expenses Annual46.71
Operating Profit Annual1.59
Interest Annual0.68
Depreciation0.37
Net Profit Annual0.24
Tax Annual0.30

Gujarat Terce Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.03
Cash Flow from Operations2.60
Cash Flow from Investing-0.46
Cash Flow from Financing-4.08
Cash Flow at the End0.09

Gujarat Terce Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)3.31
PBIT Margin (%)2.54
PBT Margin (%)-1.19
Net PROFIT Margin (%)0.50
Return On Networth / Equity (%)2.96
Return On Networth /Employed (%)7.17
Return On Assets (%)1.51
Total Debt / Equity (X)0.80
Asset Turnover Ratio (%)3.02

Gujarat Terce Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual3.69
Total Current Assets Annual11.22
Non Current Assets Annual12.05
Total Shareholders Funds Annual7.11
Total Assets Annual23.27

Gujarat Terce Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.61

Reported

0.61

Surprise

0.00%

Jun 2021

EPS beaten by 0.00%

Sep 2020

EPS beaten by 0.00%

Jun 2020

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Gujarat Terce Laboratories Ltd has a market capitalization of 39.29 Cr. Value Research classifies it as a Micro-Cap company.
No, Gujarat Terce Laboratories Ltd is not debt-free with a debt-to-equity ratio of 0.54.
In FY 2023 , Gujarat Terce Laboratories Ltd recorded a total revenue of approximately 47.97 Cr marking a significant milestone in the company's financial performance.
Gujarat Terce Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..
Gujarat Terce Laboratories Ltd's current PE ratio is 163.71.
Gujarat Terce Laboratories Ltd's ROCE averaged 1.0% from the FY ending March 2022 to 2024, with a median of 6.7%. It peaked at 9.9% in March 2024, reflecting strong capital efficiency over the period..
Gujarat Terce Laboratories Ltd's latest EBIT is Rs. 1.22 Cr, surpassing the average EBIT of Rs. 0.07 Cr over the 5 years..